 | |
| Industry | Healthcare E-commerce |
|---|---|
| Founded | 2020 |
| Founder(s) | Saurab Jain Devashish Singh |
| Headquarters | |
Area served | India |
Key people | Devashish Singh (Co-Founder & CEO) Saurab Jain (Co-Founder & CBO) |
| Revenue |  ₹16 crore (US$2.2 million) (2023)[1] |
Number of employees | 66 |
MrMed is an online pharmacy for super-specialty medicines based in India. It was founded by Devashish Singh and Saurab Jain and has its headquarters in Chennai.[2] In 2022, the company received an award from the Government of Tamil Nadu for its contributions to healthcare.[3]
History[edit | edit source]
MrMed was conceived in August 2020 when Devashish Singh[4] and Saurab Jain[5] noticed challenges in specialty medicines.[6] Despite facing initial setbacks due to the COVID Delta wave in India,[7] which prompted the founders and their team to prioritize community assistance, MrMed was officially launched in June 2021.[2] The company launched its mobile app in March 2023 for access to speciality medicines for conditions such as cancer, transplants, kidney, or liver diseases.[8] It also raised $500,000 in funding from the Tamil Nadu Emerging Sector Seed Fund (TNESSF) and angel investors.[9][10][11]
On 8 December 2025, the company announced a strategic partnership with the American multinational pharmaceutical company Eli Lilly to support the distribution of specialty medicines in India.[12][13]
Operations[edit | edit source]
MrMed's headquarters are in Chennai, with dispatch hubs located in Delhi and Bangalore. According to the Economic Times, the company reported an Annual Recurring Revenue (ARR) of ₹26 crore.[2] In April 2024, the company entered the offline retail segment with the opening of its first store in Chennai.[14]
Awards and recognition[edit | edit source]
In 2022, MrMed was awarded the Health Care Start-up Of The Year by the Federation of Indian Chambers of Commerce and Industry (FICCI) in Chennai, presented by Ma. Subramanian, the Minister for Health and Family Welfare, Government of Tamil Nadu.[15][3]
See also[edit | edit source]
References[edit | edit source]
- ↑ Borpuzari, Pranbihanga (7 November 2023). "The Economic Times".
- ↑ 2.0 2.1 2.2 Borpuzari, Pranbihanga (7 November 2023). "Economic times". ISSN 0013-0389. Retrieved 3 May 2024.
- ↑ 3.0 3.1 "MrMed awarded Start-up of the Year 2022 by FICCI by Mrmed Online Pharmacy - Issuu". issuu.com. 1 December 2022. Retrieved 3 May 2024.
- ↑ "MrMed sees 50% growth in revenue in FY24 - The Economic Times". m.economictimes.com. Retrieved 21 August 2025.
- ↑ Koul, Rahul (29 August 2023). ""Problem statement is quite unique in specialized medications"". BioVoiceNews. Retrieved 3 May 2024.
- ↑ "MrMed's contribution to drug adherence and patient engagement - Elets eHealth". eHealth Magazine. 30 May 2023. Retrieved 3 May 2024.
- ↑ "Mr Med seed fund raise: Specialty pharmacy MrMed raises $500,000 from Tamil Nadu Emerging Sector Seed Fund - The Economic Times". m.economictimes.com. Retrieved 21 August 2025.
- ↑ "MrMed launches mobile app for access to affordable super-specialty medicines". The Economic Times. 29 March 2023. ISSN 0013-0389. Retrieved 10 September 2024.
- ↑ Kandavel, Sangeetha (30 August 2023). "Online pharmacy MrMed raises $500,000 from Tamil Nadu Emerging Sector Seed Fund". The Hindu. ISSN 0971-751X. Retrieved 3 May 2024.
- ↑ "MrMed raises $500k from TNESSF". The Times of India. 31 August 2023. ISSN 0971-8257. Retrieved 3 May 2024.
- ↑ "Specialty pharmacy MrMed raises $500,000 from Tamil Nadu Emerging Sector Seed Fund". The Economic Times. 30 August 2023. ISSN 0013-0389. Retrieved 3 May 2024.
- ↑ "MrMed strengthens its network with cold-chain hub". The Hans India. 8 December 2025. Retrieved 20 December 2025.
- ↑ "MrMed announces new cold-chain hub in Bengaluru and strategic partnership with Eli Lilly". BioSpectrum. 8 December 2025. Retrieved 20 December 2025.
- ↑ "MrMed ventures into physical retail space with launch of store in Chennai". The Economic Times. 25 April 2024. ISSN 0013-0389. Retrieved 8 April 2025.
- ↑ "medgatetoday". Retrieved 3 May 2024.